Targeting Purinergic Signaling in the Dynamics of Disease Progression in Sepsis

Overview

Journal Front Pharmacol

Date 2021 Feb 1

PMID 33519492

Citations 8

Authors

Raissa Leite-Aguiar

Vinicius Santos Alves

Luiz Eduardo Baggio Savio

Robson Coutinho-Silva

Affiliations

Soon will be listed here.

Citing Articles

The P2Y receptor as a sensor of nucleotides and cell recruitment during inflammatory processes of the liver.

Alves V, Cristina-Rodrigues F, Coutinho-Silva R Purinergic Signal. 2024; 20(5):465-467.

PMID: 38627279 PMC: 11377366. DOI: 10.1007/s11302-024-10008-z.

Purinergic P2X7 receptor expression increases in leukocytes from intra-abdominal septic patients.

Martinez-Banaclocha H, Garcia-Palenciano C, Martinez-Alarcon L, Amores-Iniesta J, Martin-Sanchez F, Ercole G Front Immunol. 2023; 14:1297249.

PMID: 38094297 PMC: 10716420. DOI: 10.3389/fimmu.2023.1297249.

Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies.

Shafaghat Z, Ghomi A, Khorramdelazad H, Safari E Inflammopharmacology. 2023; 31(6):3005-3020.

PMID: 37805959 DOI: 10.1007/s10787-023-01344-4.

Platelet P2Y signalling pathway in the dysregulated immune response during sepsis.

Amoafo E, Entsie P, Kang Y, Canobbio I, Liverani E Br J Pharmacol. 2023; 181(4):532-546.

PMID: 37525937 PMC: 10830899. DOI: 10.1111/bph.16207.

P2X7 receptor contributes to long-term neuroinflammation and cognitive impairment in sepsis-surviving mice.

Alves V, da Silva J, Rodrigues F, Araujo S, Gouvea A, Leite-Aguiar R Front Pharmacol. 2023; 14:1179723.

PMID: 37153798 PMC: 10160626. DOI: 10.3389/fphar.2023.1179723.

References

Jacobson K, Delicado E, Gachet C, Kennedy C, von Kugelgen I, Li B . Update of P2Y receptor pharmacology: IUPHAR Review 27. Br J Pharmacol. 2020; 177(11):2413-2433. PMC: 7205808. DOI: 10.1111/bph.15005. View

Di Virgilio F, Tang Y, Sarti A, Rossato M . A rationale for targeting the P2X7 receptor in Coronavirus disease 19. Br J Pharmacol. 2020; 177(21):4990-4994. PMC: 7280564. DOI: 10.1111/bph.15138. View

Savio L, Coutinho-Silva R . Immunomodulatory effects of P2X7 receptor in intracellular parasite infections. Curr Opin Pharmacol. 2019; 47:53-58. DOI: 10.1016/j.coph.2019.02.005. View

Rehman A, Baloch N, Morrow J, Pacher P, Hasko G . Targeting of G-protein coupled receptors in sepsis. Pharmacol Ther. 2020; 211:107529. PMC: 7388546. DOI: 10.1016/j.pharmthera.2020.107529. View

Cauwels A, Rogge E, Vandendriessche B, Shiva S, Brouckaert P . Extracellular ATP drives systemic inflammation, tissue damage and mortality. Cell Death Dis. 2014; 5:e1102. PMC: 3973196. DOI: 10.1038/cddis.2014.70. View

Larrouyet-Sarto M, Tamura A, Alves V, Santana P, Ciarlini-Magalhaes R, Rangel T . P2X7 receptor deletion attenuates oxidative stress and liver damage in sepsis. Purinergic Signal. 2020; 16(4):561-572. PMC: 7855213. DOI: 10.1007/s11302-020-09746-7. View

Busse H, Bitzinger D, Hocherl K, Seyfried T, Gruber M, Graf B . Adenosine A2A and A2B Receptor Substantially Attenuate Ischemia/Reperfusion Injury in Septic rat Hearts. Cardiovasc Drugs Ther. 2016; 30(6):551-558. PMC: 5156668. DOI: 10.1007/s10557-016-6693-y. View

Sullivan G, Fang G, Linden J, Scheld W . A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. J Infect Dis. 2004; 189(10):1897-904. DOI: 10.1086/386311. View

Hotchkiss R, Monneret G, Payen D . Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013; 13(3):260-8. PMC: 3798159. DOI: 10.1016/S1473-3099(13)70001-X. View

10.

Martinez-Garcia J, Martinez-Banaclocha H, Angosto-Bazarra D, Torre-Minguela C, Baroja-Mazo A, Alarcon-Vila C . P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis. Nat Commun. 2019; 10(1):2711. PMC: 6586640. DOI: 10.1038/s41467-019-10626-x. View

11.

Li H, Liu L, Zhang D, Xu J, Dai H, Tang N . SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020; 395(10235):1517-1520. PMC: 7164875. DOI: 10.1016/S0140-6736(20)30920-X. View

12.

Liverani E, Rico M, Tsygankov A, Kilpatrick L, Kunapuli S . P2Y12 Receptor Modulates Sepsis-Induced Inflammation. Arterioscler Thromb Vasc Biol. 2016; 36(5):961-71. PMC: 4850113. DOI: 10.1161/ATVBAHA.116.307401. View

13.

Idzko M, Ferrari D, Eltzschig H . Nucleotide signalling during inflammation. Nature. 2014; 509(7500):310-7. PMC: 4222675. DOI: 10.1038/nature13085. View

14.

Hotchkiss R, Monneret G, Payen D . Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013; 13(12):862-74. PMC: 4077177. DOI: 10.1038/nri3552. View

15.

Wu X, Ren J, Chen G, Wu L, Song X, Li G . Systemic blockade of P2X7 receptor protects against sepsis-induced intestinal barrier disruption. Sci Rep. 2017; 7(1):4364. PMC: 5491531. DOI: 10.1038/s41598-017-04231-5. View

16.

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

17.

Dosch M, Zindel J, Jebbawi F, Melin N, Sanchez-Taltavull D, Stroka D . Connexin-43-dependent ATP release mediates macrophage activation during sepsis. Elife. 2019; 8. PMC: 6415938. DOI: 10.7554/eLife.42670. View

18.

Reinhart K, Daniels R, Kissoon N, Machado F, Schachter R, Finfer S . Recognizing Sepsis as a Global Health Priority - A WHO Resolution. N Engl J Med. 2017; 377(5):414-417. DOI: 10.1056/NEJMp1707170. View

19.

Csoka B, Nemeth Z, Szabo I, Davies D, Varga Z, Paloczi J . Macrophage P2X4 receptors augment bacterial killing and protect against sepsis. JCI Insight. 2018; 3(11). PMC: 5997389. DOI: 10.1172/jci.insight.99431. View

20.

Sumi Y, Woehrle T, Chen Y, Bao Y, Li X, Yao Y . Plasma ATP is required for neutrophil activation in a mouse sepsis model. Shock. 2014; 42(2):142-7. PMC: 4107005. DOI: 10.1097/SHK.0000000000000180. View